Sign In

Article Information

  • Banning Off-Label Drug Promotion Offends the U.S. Constitution: Making the Strongest Case

    Commentators continue to debate whether the restrictions that the U.S. Food and Drug Administration (FDA) imposes on the dissemination of information about “off-label” uses of approved therapeutic products violate the First Amendment.

Announcements